Clinical trial · Interventional
Ultrasound-guided Continuous Low Serratus Anterior Plane Block in Hepatocellular Carcinoma Surgery
The Role of Continuous Low Serratus Anterior Plane Block in Hepatocellular Carcinoma Surgery: a Randomised Clinical Trial.
NCT05531864CI-TRIAL-00074514RCTunknownN/AClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
To investigate the clinical application of ultrasound-guided continuous low serratus anterior plane block in open surgery for hepatocellular carcinoma.
Conditions
Conditions (3)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Liver Neoplasms | Liver Neoplasm | ONTOLOGY_EXACT | 0.98 |
| Postoperative Analgesia | — | UNRESOLVED | — |
| Serratus Anterior Plane Block | — | UNRESOLVED | — |
Interventions
Interventions (2)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Ultrasound-guided continuous low serratus anterior plane block | Procedure | — | UNRESOLVED |
| Ultrasound-guided single serratus anterior plane block | Procedure | — | UNRESOLVED |
Design
Arms and outcomes
Arms (2)
- type
- EXPERIMENTAL
- label
- Continuous serratus anterior plane block
- description
- Ultrasound-guided continuous serratus anterior plane block.
- interventionNames
- Procedure: Ultrasound-guided continuous low serratus anterior plane block
- type
- ACTIVE_COMPARATOR
- label
- Single serratus anterior plane block combined with rectus sheath nerve block
- description
- Ultrasound-guided single serratus anterior plane block combined with rectus sheath nerve block.
- interventionNames
- Procedure: Ultrasound-guided single serratus anterior plane block
Primary outcomes (4)
- measure
- Block plane
- timeFrame
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 18 Years
- Maximum age
- 80 Years
Show eligibility criteria text
Inclusion Criteria: 1. Age 18-60 years; 2. ASAI-II; 3. BMI: 18-29 kg/m2 Exclusion Criteria: 1. Combined cardiac, cerebral, hepatic, and renal failure; 2. Comorbid psychiatric and neuromuscular disorders; 3. A history of allergy to anesthetic drugs; 4. Participation in other recent clinical or drug trials.
References
Publications (0)
Data not yet available
No reference posted for this study.